DK478585A - 4-alkoxy-pyrido(2,3-d)pyrimidin-derivater, deres fremstilling og anvendelse - Google Patents

4-alkoxy-pyrido(2,3-d)pyrimidin-derivater, deres fremstilling og anvendelse Download PDF

Info

Publication number
DK478585A
DK478585A DK478585A DK478585A DK478585A DK 478585 A DK478585 A DK 478585A DK 478585 A DK478585 A DK 478585A DK 478585 A DK478585 A DK 478585A DK 478585 A DK478585 A DK 478585A
Authority
DK
Denmark
Prior art keywords
pyrido
preparation
pyrimidine derivatives
alcoxy
well
Prior art date
Application number
DK478585A
Other languages
English (en)
Other versions
DK478585D0 (da
Inventor
Juergen Kleinschroth
Gerhard Saltzinger
Karl Mannhardt
Johannes Hartenstein
Hartmut Osswald
Guenter Weinheimer
Edgar Fritschi
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of DK478585D0 publication Critical patent/DK478585D0/da
Publication of DK478585A publication Critical patent/DK478585A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK478585A 1984-10-19 1985-10-18 4-alkoxy-pyrido(2,3-d)pyrimidin-derivater, deres fremstilling og anvendelse DK478585A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843438351 DE3438351A1 (de) 1984-10-19 1984-10-19 4-alkoxy-pyrido(2,3-d)pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung

Publications (2)

Publication Number Publication Date
DK478585D0 DK478585D0 (da) 1985-10-18
DK478585A true DK478585A (da) 1986-04-20

Family

ID=6248308

Family Applications (1)

Application Number Title Priority Date Filing Date
DK478585A DK478585A (da) 1984-10-19 1985-10-18 4-alkoxy-pyrido(2,3-d)pyrimidin-derivater, deres fremstilling og anvendelse

Country Status (14)

Country Link
US (2) US4681882A (da)
EP (1) EP0180834B1 (da)
JP (1) JPS61100582A (da)
CN (1) CN1004274B (da)
AT (1) ATE45949T1 (da)
AU (1) AU579413B2 (da)
CA (1) CA1257261A (da)
DD (1) DD239794A5 (da)
DE (2) DE3438351A1 (da)
DK (1) DK478585A (da)
ES (1) ES8605519A1 (da)
GR (1) GR852529B (da)
HU (1) HU194227B (da)
ZA (1) ZA857989B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3438350A1 (de) * 1984-10-19 1986-04-24 Gödecke AG, 1000 Berlin 4-oxo-pyrido (2,3-d) pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung
DE3501696A1 (de) * 1985-01-19 1986-07-24 Bayer Ag, 5090 Leverkusen Pyridopyrimidine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US5059602A (en) * 1990-08-27 1991-10-22 Hoechst-Roussel Pharmaceuticals Inc. 4-substituted dihydropyrido(4,3-d)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
DE102006026583A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung
DE102006026585A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE525394A (da) *
US3673184A (en) * 1970-09-02 1972-06-27 Dainippon Pharmaceutical Co Certain 2-substituted-5,8-dihydro-5-oxopyrido{8 2,3-d{9 pyrimidine-6-carboxylic acid derivatives
US4271164A (en) * 1979-04-16 1981-06-02 Warner-Lambert Company 6-Substituted-arylpyrido[2,3-d]pyrimidin-7-amines and derivatives
US4361700A (en) * 1980-05-20 1982-11-30 James S. Waldron Pyridopyrimidinone derivatives
US4560753A (en) * 1982-11-05 1985-12-24 Sterling Drug Inc. 2-Substituted-pyrido[2,3-d]pyrimidin-5(8H)-ones
US4432981A (en) * 1982-11-05 1984-02-21 Sterling Drug Inc. 2-(Pyridinyl or hydroxyphenyl)-8-substituted pyrido[2,3-d]pyrimidin-5(8H)-ones
DE3438350A1 (de) * 1984-10-19 1986-04-24 Gödecke AG, 1000 Berlin 4-oxo-pyrido (2,3-d) pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
DK478585D0 (da) 1985-10-18
AU579413B2 (en) 1988-11-24
HUT39181A (en) 1986-08-28
EP0180834A1 (de) 1986-05-14
DE3572663D1 (en) 1989-10-05
CA1257261A (en) 1989-07-11
ATE45949T1 (de) 1989-09-15
CN1004274B (zh) 1989-05-24
ES8605519A1 (es) 1986-03-16
ES548008A0 (es) 1986-03-16
AU4885685A (en) 1986-04-24
DD239794A5 (de) 1986-10-08
DE3438351A1 (de) 1986-04-24
CN85107614A (zh) 1986-07-16
EP0180834B1 (de) 1989-08-30
US4681882A (en) 1987-07-21
GR852529B (da) 1986-02-19
JPS61100582A (ja) 1986-05-19
ZA857989B (en) 1986-06-25
HU194227B (en) 1988-01-28
US4762837A (en) 1988-08-09

Similar Documents

Publication Publication Date Title
NO880182L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater.
DK478585A (da) 4-alkoxy-pyrido(2,3-d)pyrimidin-derivater, deres fremstilling og anvendelse
SE8304737L (sv) Karbostyrilderivat
IT1194521B (it) Carbossamido-derivati di 1,2,4-tiadiazolo (3,2-a) pirimidine e procedimento per la loro preparazione
EP0179808A4 (en) MEDICINAL COMPOSITION SUITABLE FOR TREATING OR PROPHYLAXIS OF HEART DISORDERS.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO871867D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske kondenserte tricykliske forbindelser.
NO164542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)-pyrimidinderivater.
NO874302D0 (no) Fremgangsmaate for fremstilling av 4,5-dihydro- og 4,5,6,7-tetrahydro- pyrazolo (1,5-a)pyrimidiner.
NO168037C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater.
SE8301004D0 (sv) Pyridinforeningar
NO167028C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)pyrimidinderivater
NO881190D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 9- (beta-d-deoxyribofuranosyl)-mucleosider.
NO881768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
DK478485A (da) 4-oxo-pyrido(2,3-d)pyrimidin-derivater, deres fremstilling og anvendelse
IT1193604B (it) 1,3,4-tiadiazolo (3,2-a) pirimidine sostituite e procedimento per la loro preparazione
NO854277L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 6-fenetylaminoalkyl-7-hydroksy-furo-(3,4-c)-pyridin-derivater.
IT1223416B (it) Procedimento per la realizzazione di calzature del tipo ciabatta, nonche' ciabatta cosi' realizzata
NO167511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater.
NO880127D0 (no) Fremgangsmaate for fremstilling av (+-)-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1,7-dicarboxylater.
ES521739A0 (es) Procedimiento para preparar derivados cicloalifaticos condensados de pirido(1,2-a)pirimidinas sustituidas.
NO880492D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske triazolpyrimidinderivater.
IT8421753A0 (it) Agenti terapeutici per il trattamento di disturbi cardiaci edella circolazione, delle dislipidemie e delle deficienze delle prestazioni muscolari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8420949A1 (it) " Farmaco per la terapia dell'ipertensione arteriosa e dell'infarto del miocardio."
NO163530C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-substituerte-5-fenyltetrazolo-(1,5-a) (1,2,4)-triazolo(1,5-c)pyrimidiner.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment